ARKG
ARK Genomic Revolution ETF
Overview
Fund Objective
ARKG is an actively managed Exchange Traded Fund (ETF) that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy, and consumer discretionary, that are relevant to the Fund’s investment theme of the genomics revolution.
Fund Description
Companies within ARKG are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business. ARKG will be concentrated in issuers in any industry or group of industries in the health care sector, including issuers having their principal business activities in the biotechnology industry. The companies held in ARKG may be leaders, enablers, or beneficiaries of technologies including:
- CRISPR
- Targeted Therapeutics
- Bioinformatics
- Molecular Diagnostics
- Stem Cells
- Agricultural Biology
Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal will fluctuate so that an investor’s shares when redeemed may be worth more or less than the original cost. Extraordinary performance is attributable in part due to unusually favorable market conditions and may not be repeated or consistently achieved in the future. The Fund’s most recent month-end performance can be found in the fund material section.
Returns for less than one year are not annualized. Net asset value (“NAV”) returns are based on the dollar value of a single share of the ETF, calculated using the value of the underlying assets of the ETF minus its liabilities, divided by the number of shares outstanding. The NAV is typically calculated at 4:00 pm Eastern time on each business day the New York Stock Exchange is open for trading. Market returns are based on the trade price at which shares are bought and sold on the NYSE Arca, Inc. using the last share trade. Market performance does not represent the returns you would receive if you traded shares at other times. Total Return reflects the reinvestment of distributions on ex-date for NAV returns and payment date for Market Price returns. The market price of the ETF’s shares may differ significantly from their NAV during periods of market volatility.
Top 10 Holdings
As of 07/05/2023
The performance of your investment in the Fund, as well as the returns you attain, may encounter fluctuations. We wish to underscore that your investment enjoys the safeguard of SIPC insurance, assuring protection against loss due to insolvency. Furthermore, in adverse scenarios, we extend an added layer of security by facilitating a capital refund. Despite potential investment challenges, these measures are meticulously designed to mitigate risks and in still confidence in your investment choices. Prior to contemplating an investment in the Fund, we urge you to diligently assess the ensuing risks. Each of the summarized risks below maintains its status as a “principal risk” associated with investing in the Fund, irrespective of their order of presentation.
